Market Overview: The global
analgesic infusion pumps market reached a value of USD 1.17 Billion in 2022
and is projected to attain USD 1.72 Billion by 2032, with a compound annual
growth rate (CAGR) of 4.4% during the forecast period. Key drivers for this
growth include the increasing prevalence of chronic pain among the elderly, a
growing demand for pain management during surgical procedures, and a rising
number of surgeries performed worldwide.
Elderly individuals commonly suffer from chronic pain,
necessitating long-term analgesic therapy. Consequently, the geriatric
population is exhibiting a heightened demand for analgesic infusion pumps,
which is anticipated to fuel market growth throughout the forecast period.
Analgesic infusion pumps are increasingly being used in surgical
procedures due to their ability to provide targeted pain relief while
minimizing side effects. Their application in post-operative pain management is
on the rise, as they effectively deliver continuous, focused pain relief.
Get a sample copy of theAnalgesic Infusion Pumps Market report:
https://www.reportsanddata.com/download-free-sample/6211
The surge in surgical procedures worldwide is contributing to
the growing demand for analgesic infusion pumps. The necessity for efficient
pain management during surgical procedures is further propelling the market's
revenue growth.
The market is also benefiting from the increasing popularity
of ambulatory infusion pumps, which are portable and lightweight, making them
ideal for patients in need of continuous infusion therapy who wish to maintain
their mobility.
Moreover, the rising prevalence of cancer is a significant
factor driving revenue growth in the analgesic infusion pumps market, as cancer
patients often experience chronic pain that requires ongoing pain management.
Key Insights:
Product Type:The global analgesic infusion pumps market is categorized
into Patient-Controlled Analgesia (PCA) Pumps, ambulatory infusion pumps,
disposable infusion pumps, and others based on application. In 2022, the PCA
pumps segment accounted for the largest share of revenue. PCA pumps are
commonly used in hospitals to allow patients to self-administer pain
medication, enhancing pain management and reducing healthcare costs. Healthcare
professionals prefer PCA pumps due to their simplicity and convenience, which
is expected to drive growth in this segment.
The ambulatory infusion pumps segment is anticipated to
achieve the highest CAGR in revenue during the forecast period. These pumps are
designed to provide patients with medication outside of a hospital setting,
enabling them to receive care while maintaining their regular routines. The
demand for ambulatory infusion pumps is expected to rise with the increasing
prevalence of chronic diseases such as cancer and diabetes, as well as the
popularity of home healthcare services and the transition to value-based care.
The disposable infusion pump segment is expected to exhibit a
significantly rapid CAGR in revenue during the forecast period. These pumps are
cost-effective for healthcare providers since they are single-use and
disposable after use. They also reduce the risk of infection transmission, making
them a safe choice for patients. These factors are contributing to the revenue
growth of this segment.
Application:Based on application, the global analgesic infusion pumps
market is divided into Cancer Pain, labor pain, postoperative pain, and others.
The cancer pain segment held the largest share of revenue in 2022, as analgesic
infusion pumps are used to manage the prevalent symptom of cancer pain. With
increasing cancer rates worldwide and the availability of a variety of
analgesic medications, both opioids and non-opioids, this segment is expected
to see continued growth.
The labor pain segment is projected to experience a
significantly rapid CAGR in revenue during the forecast period. Analgesic
infusion pumps are employed for managing labor pain, which is a typical symptom
of childbirth for women. The rising acceptance of pain management strategies
during childbirth, increasing awareness of the benefits of analgesic infusion
pumps, and the demand for painless childbirth are driving the growth of this
segment.
The postoperative pain segment is also anticipated to
register a significantly rapid CAGR in revenue during the forecast period.
Postoperative pain is a common occurrence following surgery, and analgesic
infusion pumps are effective in managing this discomfort. The segment's growth
is attributed to the increasing number of surgeries performed worldwide, the
utilization of pain management strategies, and the availability of a variety of
analgesic medications.
Regional Insights:In 2022, North America accounted for the largest share of
revenue in the market. This is primarily due to factors such as the increasing
elderly population and a higher prevalence of chronic diseases. The market in
North America benefits from favorable reimbursement policies and a
well-established healthcare infrastructure. The United States held the largest
share of revenue within North America, driven by the rising prevalence of
chronic diseases and an increasing elderly population.
The Asia Pacific market is expected to register the fastest
CAGR in revenue during the forecast period. This growth is attributed to the
region's focus on expanding healthcare access and improving healthcare
facilities, particularly in countries like China and India. Increasing
disposable income, a growing demand for innovative medical devices, favorable
government initiatives, and healthcare infrastructure investments are expected
to drive revenue growth in the region.
The European market is projected to account for a moderately
large share of revenue during the forecast period. This is driven by the
increasing prevalence of chronic diseases and the adoption of innovative
medical technology. The United Kingdom dominates the European market due to its
utilization of new medical technology, supportive government policies, and the
presence of leading infusion pump manufacturers.
Competitive Landscape:The analgesic infusion pumps market is highly competitive,
with several major players vying for market share. Key companies in this market
include Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG,
Halyard Health, Hospira Inc. (Pfizer Inc.), Medtronic, Smiths Medical (Smiths
Group plc), Terumo Corporation, and Zyno Medical. These companies continuously
innovate by developing new products and technologies to enhance patient
outcomes and reduce costs. They also engage in strategic alliances and
acquisitions to expand their product portfolios and increase their market
presence.
Report Scope:
Explore Trending Reports:
Cellulose
Ether Market-https://www.globenewswire.com/news-release/2019/07/18/1884739/0/en/Cellulose-Ether-Market-To-Reach-USD-8-68-Billion-By-2026-Reports-And-Data.html
Synthetic
Gypsum Market-https://www.globenewswire.com/news-release/2019/09/16/1916025/0/en/Synthetic-Gypsum-Market-To-Reach-USD-1-89-Billion-By-2026-Reports-And-Data.html
Dimethylformamide
(DMF) Market-https://www.globenewswire.com/news-release/2019/11/21/1951122/0/en/Dimethylformamide-DMF-Market-To-Reach-USD-923-9-Million-By-2026-Reports-And-Data.html
Optical
Brighteners Market-https://www.globenewswire.com/news-release/2020/05/06/2028786/0/en/Optical-Brighteners-Market-To-Reach-USD-1-44-Billion-By-2027-Reports-and-Data.html
Request a customization of the report:https://www.reportsanddata.com/request-customization-form/6211
Thank
you for reading our report. To know more about the customization or any query
about the report contents, please connect with us and our team will ensure the
report is tailored to meet your requirements.
About Reports and Data
Reports
and Data is a market research and consulting company that provides syndicated
research reports, customized research reports, and consulting services. Our
solutions purely focus on your purpose to locate, target, and analyse consumer
behaviour shifts across demographics, across industries, and help clients to
make smarter business decisions. We offer market intelligence studies ensuring
relevant and fact-based research across multiple industries, including
Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently
update our research offerings to ensure our clients are aware of the latest
trends existent in the market. Reports and Data has a strong base of
experienced analysts from varied areas of expertise. Our industry experience
and ability to develop a concrete solution to any research problems provides
our clients with the ability to secure an edge over their respective
competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press
Release: https://www.reportsanddata.com/press-release
The Wall